On July 25, 2019, ProteinQure announced its US$4 million Seed round led by Felicis Ventures with participation from 8VC, Golden Ventures, iNovia, Global Founders Capital and angel investor Tom Williams. ProteinQure plans to use this financing to continue adding top interdisciplinary talent to their team and expanding their partnerships with industry leaders.
ProteinQure, a Toronto-based biotech firm, is combining quantum annealing and reinforcement learning to lower the cost and increase speed of the drug development. ProteinQure leverages new and upcoming advances in computing architectures, from high-performance GPUs, TPUs, and specialized circuits, all the way to quantum computers.
Osler, Hoskin, & Harcourt LLP advised ProteinQure with a team led by Chad Bayne, consisting of Justin Dharamdial and Horatiu Porime (Emerging and High Growth Companies).